Prevention is Powerful! But How do You Measure it?

✨ How do you turn a bold vision for preventive health into hard, data-driven impact metrics that investors can trust? 📊

‍

💡We are thrilled to share that Thier has been featured in a dedicated case study by the CLARIFAI Project and Tau20 following our participation in the Tau20 Impact Readiness Sprint! Funded by the European Union.🚀

At Thier, our mission is clear: intercepting chronic lifestyle conditions (like Type II diabetes and obesity) 2–5 years before clinical onset using predictive AI, real-time biometrics, and voice interventions.

But when communicating with the global investment community, subjective impact goals aren't enough data is everything.Through the Tau20 sprint supported by EBAN - European Business Angel Network (European Business Angels Network) and fasttrack ventures, we worked closely with impact experts to:

🎯 Map our platform's outputs directly to UN Sustainable Development Goals (SDGs) and IRIS+ metrics.

📈 Sharpen our core impact narrative into a precise, quantitative Impact Readiness Index (IRX).

🛡️ Ensure our preventive health ROI is transparent, measurable, and investor-ready.

A huge thank you to Mirko Hirschmann, Head of Impact, Measurement and Management at Tau20 the entire Tau20 and Clarifai project team for giving us the structure and clarity to prove that financial return and positive health impact move in complete alignment.

👉 Read the full case study here: https://www.clarifaiproject.eu/thier-tau20/

Curious what your own impact could look like? Try Tau20 for FREE, and start measuring what matters. https://www.tau20.com/

‍

‍